Firefly Neuroscience shares surge 11.32% premarket after launching CLEAR platform with NVIDIA GPU acceleration to enhance EEG data and biomarker discovery.

Firefly Neuroscience (NASDAQ:AIFF) surged 11.32% in premarket trading, driven by two key announcements. The company launched its CLEAR platform, which enhances EEG data quality and accelerates brain biomarker discovery, and successfully integrated NVIDIA’s L40S GPU to power next-generation research. These advancements highlight Firefly’s progress in AI-driven neuroscience and its collaboration with a leading tech provider, signaling strong technical and commercial potential. The news aligns with broader investor interest in AI applications for healthcare innovation, particularly as Firefly’s FDA-cleared BNA™ platform gains traction in precision research. Recent partnerships, including one with Heidelberg University, and prior additions to the Russell Microcap Index further reinforce the stock’s momentum. The premarket rally reflects optimism about Firefly’s expanding capabilities and market positioning in the brain health technology sector.